By expenditures
| Name | Title | Type |
|---|---|---|
| Jean Scrimgeour | Chief Innovation And Operations Officer | Auditee |
| Max Manley | Director | Auditee |
| James M. Larson | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 368022 | 2024 | 2025-09-26 | Han Group LLC | $4.84M |
| 316094 | 2023 | 2024-07-29 | Gelman Rosenberg & Freedman | $4.38M |
| 26211 | 2022 | 2023-06-06 | Gelman Rosenberg & Freedman | $2.49M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 368022 | 2024 | 2025-09-26 | 1155726 | 2024-003 | Material Weakness | Yes | L |
| 316094 | 2023 | 2024-07-29 | 1055987 | 2023-001 | Significant Deficiency | - | L |
| 316094 | 2023 | 2024-07-29 | 1055986 | 2023-002 | Significant Deficiency | - | M |
| 316094 | 2023 | 2024-07-29 | 1055985 | 2023-001 | Significant Deficiency | - | L |
| 316094 | 2023 | 2024-07-29 | 1055984 | 2023-001 | Significant Deficiency | - | L |
| 316094 | 2023 | 2024-07-29 | 1055983 | 2023-002 | Significant Deficiency | - | M |
| 316094 | 2023 | 2024-07-29 | 1055982 | 2023-001 | Significant Deficiency | - | L |
| 316094 | 2023 | 2024-07-29 | 1055981 | 2023-002 | Significant Deficiency | - | M |
| 316094 | 2023 | 2024-07-29 | 1055980 | 2023-001 | Significant Deficiency | - | L |
| 316094 | 2023 | 2024-07-29 | 1055979 | 2023-001 | Significant Deficiency | - | L |
| 316094 | 2023 | 2024-07-29 | 1055978 | 2023-001 | Significant Deficiency | - | L |
| 316094 | 2023 | 2024-07-29 | 479545 | 2023-001 | Significant Deficiency | - | L |
| 316094 | 2023 | 2024-07-29 | 479544 | 2023-002 | Significant Deficiency | - | M |
| 316094 | 2023 | 2024-07-29 | 479543 | 2023-001 | Significant Deficiency | - | L |
| 316094 | 2023 | 2024-07-29 | 479542 | 2023-001 | Significant Deficiency | - | L |
| 316094 | 2023 | 2024-07-29 | 479541 | 2023-002 | Significant Deficiency | - | M |
| 316094 | 2023 | 2024-07-29 | 479540 | 2023-001 | Significant Deficiency | - | L |
| 316094 | 2023 | 2024-07-29 | 479539 | 2023-002 | Significant Deficiency | - | M |
| 316094 | 2023 | 2024-07-29 | 479538 | 2023-001 | Significant Deficiency | - | L |
| 316094 | 2023 | 2024-07-29 | 479537 | 2023-001 | Significant Deficiency | - | L |
| 316094 | 2023 | 2024-07-29 | 479536 | 2023-001 | Significant Deficiency | - | L |